3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
4
Pain, Postoperative
3
Pain
2
Lung Neoplasms
2
Colonic Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Spondylitis, Ankylosing
1
Pituitary Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Mucositis
1
Lymphoma, Follicular
1
Inflammation
1
Endometrial Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Anastomotic Leak
1
Adenocarcinoma of Lung
1
Acute Pain
1
Interventions
Cyclophosphamide
21
Cytarabine
15
blinatumomab
13
fludarabine
12
Azacitidine
10
venetoclax
9
fludarabine phosphate
9
Blood Specimen Collection
8
Methotrexate
7
Lenalidomide
7
Dexamethasone
7
Rituximab
6
Mercaptopurine
6
Daunorubicin
6
Vincristine
5
daratumumab
4
Whole-Body Irradiation
4
Melphalan
4
Etoposide
4
Busulfan
4
obinutuzumab
3
Radiotherapy
3
Neoadjuvant Therapy
3
Maintenance
3
Liquid Biopsy
3
Immunotherapy, Adoptive
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Drug Therapy
3
Doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm, Residual
×
Anti-Inflammatory Agents, Non-Steroidal
×
Clear all
NCT03330769
2019-04-17
UPSTREAM
University of Cagliari
Unknown
250 enrolled